Heart failure patients may get a boost from a common gout drug
NCT ID NCT06130059
First seen Feb 28, 2026 · Last updated Apr 29, 2026 · Updated 8 times
Summary
This study tests whether a low dose of colchicine, a drug typically used for gout, can improve exercise capacity in people with a type of heart failure called HFpEF who also have signs of inflammation. About 60 participants will be randomly assigned to receive either colchicine or a placebo for 3 months. Researchers will measure changes in exercise tests, physical function, and quality of life to see if the drug helps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75235, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.